|
SBNO1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.88230000003542E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.982700E-03 |
| Normal-vs-Stage2 |
9.033500E-04 |
| Normal-vs-Stage3 |
7.20649999674805E-08 |
| Normal-vs-Stage4 |
1.8808999999731E-06 |
| Stage1-vs-Stage2 |
1.283850E-01 |
| Stage1-vs-Stage3 |
1.030030E-04 |
| Stage1-vs-Stage4 |
1.383540E-03 |
| Stage2-vs-Stage3 |
1.944840E-01 |
| Stage2-vs-Stage4 |
2.841000E-01 |
| Stage3-vs-Stage4 |
9.123000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.94311999999197E-05 |
| Normal-vs-AfricanAmerican |
2.45519999997335E-06 |
| Normal-vs-Asian |
9.875200E-01 |
| Caucasian-vs-AfricanAmerican |
4.965600E-02 |
| Caucasian-vs-Asian |
1.745040E-01 |
| AfricanAmerican-vs-Asian |
4.585500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.7070000000462E-06 |
| Normal-vs-Female |
6.041900E-04 |
| Male-vs-Female |
3.462600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.829800E-04 |
| Normal-vs-Age(41-60Yrs) |
6.027400E-04 |
| Normal-vs-Age(61-80Yrs) |
2.42379999999542E-05 |
| Normal-vs-Age(81-100Yrs) |
2.573500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.741780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.225800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.623600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.650190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.416400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.428800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.677800E-01 |
| Normal-vs-Grade 2 |
2.803900E-03 |
| Normal-vs-Grade 3 |
2.77360000000559E-06 |
| Normal-vs-Grade 4 |
1.24919999999751E-06 |
| Grade 1-vs-Grade 2 |
3.686400E-01 |
| Grade 1-vs-Grade 3 |
1.318770E-01 |
| Grade 1-vs-Grade 4 |
4.435600E-02 |
| Grade 2-vs-Grade 3 |
5.144400E-02 |
| Grade 2-vs-Grade 4 |
3.856100E-03 |
| Grade 3-vs-Grade 4 |
1.595800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.219700E-02 |
| Normal-vs-ccB subtype |
4.35890000000105E-05 |
| ccA subtype-vs-ccB subtype |
1.381900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.040600E-04 |
| Normal-vs-N1 |
8.388400E-02 |
| N0-vs-N1 |
7.441000E-01 |
|
|
